VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GEHCGE HealthCare Technologies Inc.
$65.76$29.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksGEHCQuarterly Financials

GE HealthCare Technologies Inc. (GEHC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

GE HealthCare Technologies Inc. (GEHC) quarterly income statement — complete revenue, gross profit & net income history

GEHC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue5.13B4.67B5.14B5.01B4.78B5.32B4.86B4.84B4.65B5.21B4.82B4.82B
Revenue Growth %7.41%-12.13%5.76%3.45%2.73%2.17%0.85%0.46%-1.21%5.43%--
Cost of Goods Sold3.15B2.13B3.15B3.02B2.77B3.04B2.84B2.84B2.75B3.05B2.89B2.88B
COGS % of Revenue61.47%45.66%61.31%60.39%57.88%57.23%58.36%58.63%59.12%58.59%59.87%59.73%
Gross Profit1.98B2.54B1.99B1.99B2.01B2.27B2.03B2B1.9B2.16B1.94B1.94B
Gross Margin %38.53%54.3%38.69%39.65%42.12%42.77%41.66%41.37%40.9%41.41%40.13%40.27%
Gross Profit Growth %-1.74%11.56%-1.78%-0.85%5.78%5.52%4.7%3.2%0.58%11.59%--
Operating Expenses1.46B1.88B1.34B1.33B1.38B1.47B1.35B1.39B1.36B1.47B1.32B1.37B
OpEx % of Revenue28.49%40.14%26%26.55%28.95%27.71%27.74%28.81%29.27%28.18%27.33%28.44%
Selling, General & Admin1.12B1.04B1.04B1.03B1.04B1.13B1.03B1.07B1.04B1.15B996M1.07B
SG&A % of Revenue21.77%22.17%20.32%20.56%21.77%21.24%21.26%22.05%22.32%22.13%20.66%22.25%
Research & Development345M362M292M302M344M344M316M327M324M315M322M298M
R&D % of Revenue6.72%7.75%5.68%6.03%7.2%6.47%6.5%6.76%6.97%6.05%6.68%6.19%
Other Operating Expenses01000K0-1000K-1000K0-1000K0-1000K000
Operating Income515M664M653M654M629M801M676M608M540M689M617M570M
Operating Margin %10.04%14.21%12.7%13.06%13.17%15.06%13.9%12.56%11.61%13.23%12.8%11.83%
Operating Income Growth %-18.12%-17.1%-3.4%7.57%16.48%16.26%9.56%6.67%-3.4%-11.33%--
EBITDA530M1.21B801M802M765M941M819M757M688M833M770M726M
EBITDA Margin %10.33%25.93%15.57%16.02%16.01%17.69%16.84%15.64%14.8%16%15.97%15.07%
EBITDA Growth %-30.72%28.8%-2.2%5.94%11.19%12.97%6.36%4.27%-3.91%-10.81%--
D&A (Non-Cash Add-back)0548M148M148M136M140M143M149M148M144M153M156M
EBIT530M317M754M726M803M945M788M709M650M755M774M692M
Net Interest Income-96M-121M-111M-107M-111M-111M-125M-131M-138M-124M-132M-137M
Interest Income0-18M12M6M005M007M6M0
Interest Expense96M103M123M113M111M111M130M131M138M131M138M137M
Other Income/Expense-10M-462M-10M-41M63M33M-18M-30M-28M-80M19M0
Pretax Income505M202M643M613M692M834M658M578M512M609M636M570M
Pretax Margin %9.84%4.32%12.5%12.25%14.49%15.68%13.53%11.94%11.01%11.7%13.19%11.83%
Income Tax94M54M179M113M104M96M168M143M124M193M250M137M
Effective Tax Rate %18.61%26.73%27.84%18.43%15.03%11.51%25.53%24.74%24.22%31.69%39.31%24.04%
Net Income389M184M446M486M564M720M471M428M374M403M375M418M
Net Margin %7.58%3.94%8.67%9.71%11.81%13.54%9.69%8.84%8.04%7.74%7.78%8.68%
Net Income Growth %-31.03%-74.44%-5.31%13.55%50.8%78.66%25.6%2.39%0.54%-27.26%--
Net Income (Continuing)411M148M464M500M588M738M490M435M388M416M386M433M
Discontinued Operations0000000000-1000K0
Minority Interest230M220M227M241M231M206M195M193M191M177M172M221M
EPS (Diluted)0.850.380.981.061.231.571.020.930.810.880.820.91
EPS Growth %-30.89%-75.8%-3.92%13.98%51.85%78.41%24.39%2.2%97.56%-27.87%--
EPS (Basic)0.850.410.981.061.231.581.030.940.820.890.820.92
Diluted Shares Outstanding457M460.27M457M458M459M459M459M459M459M458M458M458M
Basic Shares Outstanding456M456.52M456M457M457M457M457M457M456M455M455M455M
Dividend Payout Ratio4.11%8.7%3.59%3.29%2.84%1.94%2.76%3.27%3.74%3.23%3.73%3.35%